Physician profile
Scott A Bailey
NPI 1477528867
$6,566.76
in general payments reported to CMS, 2019-2025
28 companies · $596 in 2025
The $596 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,539 · 2020: $230 · 2021: $772 · 2022: $588 · 2023: $577 · 2024: $265 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,437.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $3,417.82 | 2019-2024 | |
| Abbvie INC. | $913.09 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $364.84 | 2023-2025 | Veozah |
| Caldera Medical, INC | $221.79 | 2023-2025 | Desara |
| Mayne Pharma Commercial LLC | $170.57 | 2021-2023 | |
| Pfizer INC. | $153.86 | 2019-2024 | |
| Hologic Sales and Service, LLC | $132.52 | 2021-2023 | Myosure Tissue Removal Device, Novasure |
| Organon LLC | $126.95 | 2021-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $122.85 | 2023-2025 | Myfembree, Gemtesa |
| Baxter Healthcare | $111.11 | 2022 | |
| Medtronic, INC. | $96.75 | 2021-2024 | Interstim, Ligasure |
| Coloplast Corp | $92.13 | 2019-2020 | |
| Biogen, INC. | $92.06 | 2025 | Zurzuvae |
| Ethicon US, LLC | $80.99 | 2019 | |
| Millicent US INC | $78.41 | 2025 | Intrarosa, Femlyv |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $67.33 | 2021-2023 | Slynd |
| Pacira Pharmaceuticals Incorporated | $47.80 | 2023 | Exparel |
| Myovant Sciences INC. | $46.63 | 2022 | |
| Allergan, INC. | $38.41 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.71 | 2023-2024 | |
| Covidien Lp | $35.95 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $25.20 | 2021 | |
| Mylan Pharmaceuticals INC. | $22.00 | 2022 | |
| Coopersurgical, INC. | $20.05 | 2021 | |
| Medline Industries Lp | $15.73 | 2022 | |
| Urovant Sciences INC | $15.14 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $12.82 | 2022 | |
| Meditrina | $6.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.